Today: 1 April 2025
17 June 2021
2 mins read

Abu Dhabi receives new anti-Covid medication

With the arrival of the first shipment yesterday at Abu Dhabi airport, Abu Dhabi becomes the first city in the world to receive this drug….reports Asian Lite News

The world’s newest anti-viral treatment for COVID-19, Sotrovimab, is now available for early treatment of certain categories of COVID-19 patients in the UAE.

This was following a landmark agreement between the Department of Health – Abu Dhabi, leading Group Purchasing Organisation (GPO), Rafed, and global innovative biopharmaceutical company, GlaxoSmithKline (GSK).

With the arrival of the first shipment yesterday at Abu Dhabi airport, Abu Dhabi becomes the first city in the world to receive this drug.

Sotrovimab is a monoclonal antibody treatment delivered through intravenous therapy. Sotrovimab can be used to treat adults and children above the age of 12 who meet certain criteria and are at risk of progressing to severe COVID-19, as per protocols that have been developed by the National Scientific Committee.

Studies have shown the medicine to prevent hospitalisation and death in 85% of early selected treatment cases and can work on all known variations to date.

Following US Food and Drug Administration’s emergency use authorisation, the UAE Ministry of Health and Prevention issued its endorsement of the new GSK medicine following a national assessment.

The agreement is to ensure deliveries as early as June and July, enabling patients in the UAE to be among the first in the world to access the new therapy.

Abu Dhabi-based Rafed will facilitate the procurement, storage and distribution of Sotrovimab via the Rafed Distribution Center – the region’s largest specialised cold-storage facility.

Dr. Jamal Mohamed Kaabi, Undersecretary for the Department of Health- Abu Dhabi, said: “This medicine is at the forefront of pharmaceutical advancement and is a powerful tool in our fight to end this pandemic. We are looking forward to implementing the eligibility criteria for emergency use of Sotrovimab as part of Abu Dhabi’s commitment to lead an all-encompassing COVID -19 response in prevention, treatment and care.”

Rashed Al Qubaisi, CEO of Rafed said: “Sotrovimab represents a massive breakthrough in the fight against COVID-19. Through our close collaboration and partnership with the Department of Health and GSK, we have been able to work swiftly in the procurement of the medication to ensure an effective and timely roll-out across the UAE.”

ALSO READ: Scanners to detect potential Covid-19 cases in Abu Dhabi

Previous Story

Expo, UN Global Compact to organise sustainability forum

Next Story

Arab League warns against Lebanon political crisis

Latest from -Top News

Indian-American Takes Office as Head of NIH

Born in Kolkata, India, Dr. Bhattacharya earned both his BA and MA degrees in economics from Stanford University, followed by a doctorate in medicine and a PhD in economics from the same

Trump-Putin bhai, bhai

The closer Trump and Putin get Britain, France and other Western countries which, since the end of the Second World War, have seen America as an ally, will have to rethink their

‘Harry is a bully’

Sophie Chandauka says duke unleashed ‘Sussex machine’ but source close to ex-trustees claims accusation baseless The chair of a charity established by Prince Harry has accused him of “harassment and bullying at
Go toTop

Don't Miss

Joint UAE-Bahraini nanosatellite set to launch tomorrow

The joint UAE-Bahraini nanosatellite Light-1 will be launched to the

ERC Launches Ramadan Ration Project in Yemen

The project aims to bring joy and happiness during Ramadan